158800-83-0
七叶皂苷 IIb(escin IIb)
CAS: 158800-83-0
化学式: C54H84O23
| 中文名 | 七叶皂苷 IIb |
| 英文名 | escin IIb |
| 别名 | 七叶皂苷D 七叶皂苷 IIB 七叶皂苷 IIb |
| 英文别名 | EscinID escin IIb ESCIN IIB 06035642G6 AESCIN IIB 2)]-β-D-glucopyranosiduronic acid b-D-Glucopyranosiduronic acid, (3b,4b,16a,21b,22a)-22-(acetyloxy)-16,23,28-trihydroxy-21-[[(2Z)-2-methyl-1-oxo-2-butenyl]oxy]olean-12-en-3-ylO-b-D-glucopyranosyl-(14)-O-[b-D-xylopyranosyl-(12)]- β-D-Glucopyranosiduronic acid, (3β,4β,16α,21β,22α)-22-(acetyloxy)-16,23,28-trihydroxy-21-[[(2Z)-2-methyl-1-oxo-2-butenyl]oxy]olean-12-en-3-yl O-β-D-glucopyranosyl-(1→4)-O-[β-D-xylopyranosyl-(1→2)]- |
| CAS | 158800-83-0 |
| 化学式 | C54H84O23 |
| 分子量 | 1101.23 |
| InChI | InChI=1/C54H84O23/c1-10-23(2)45(69)77-42-43(71-24(3)58)54(22-57)26(17-49(42,4)5)25-11-12-30-50(6)15-14-32(51(7,21-56)29(50)13-16-52(30,8)53(25,9)18-31(54)60)73-48-40(75-46-36(64)33(61)27(59)20-70-46)38(66)39(41(76-48)44(67)68)74-47-37(65)35(63)34(62)28(19-55)72-47/h10-11,26-43,46-48,55-57,59-66H,12-22H2,1-9H3,(H,67,68)/b23-10-/t26-,27+,28+,29+,30+,31+,32-,33-,34+,35-,36+,37+,38-,39-,40+,41-,42-,43-,46-,47-,48+,50-,51+,52+,53+,54-/m0/s1 |
| 密度 | 1.45±0.1 g/cm3 (20 ºC 760 Torr) |
| 熔点 | 197.3-199°C |
| 沸点 | 1111.9±65.0 °C(Predicted) |
| 比旋光度 | (MeOH)-19.4 |
| 闪点 | 305.474°C |
| 蒸汽压 | 0mmHg at 25°C |
| 溶解度 | 在水和甲醇中易溶，在乙醇和丁醇中溶解，在氯仿和乙酸中不溶。 |
| 折射率 | 1.624 |
| 酸度系数 | 2.63±0.70(Predicted) |
| 存储条件 | 2-8℃ |
| 敏感性 | Easily absorbing moisture |
| 外观 | 白色粉末 |
| 物化性质 | |
| 体内研究 | Escins Ia, Ib, IIa, and IIb (50-200 mg/kg) inhibit the increase of vascular permeability induced by both acetic acid in mice and histamine in rats. Escins Ib, IIa, and IIb (50-200 mg/kg) also inhibit that induced by serotonin in rats, but escin Ia didn't. Escins Ia, Ib, IIa, and IIb (200 mg/kg) inhibit the hind paw edema induced by carrageenin at the first phase in rats. Escin Ia (200 mg/kg) and escins Ib, IIa, and IIb (50-200 mg/kg) inhibit the scratching behavior induced by compound 48/80 in mice, but escin Ia was weakest. Escin IIb (10-50 mg/kg; p.o.) potently inhibits ethanol-induced gastric mucosal lesions. Animal Model: Male Sprague–Dawley rats (Ethanol-induced gastric mucosal lesions in rats) Dosage: P.o. Administration: 10-50 mg/kg Result: Showed a potent protective effect against ethanol-induced gastric lesions in rats. |
供应商列表
您刚刚浏览过
你知道吗？
微信搜索化工百科或扫描下方二维码，添加化工百科小程序，随时随地查信息！